23 September 2022 in bioRxiv
Spatial and genomic heterogeneity of tumors is the key for cancer progression, treatment, and survival. However, a technology for direct mapping the clones in the tumor tissue based on point mutations is lacking. Here, we propose Tumoroscope, the first probabilistic model that accurately infers cancer clones and their high-resolution localization by integrating pathological images, whole exome sequencing, and spatial transcriptomics data. In contrast to previous methods, Tumoroscope explicitly addresses the problem of deconvoluting the proportions of clones in spatial transcriptomics spots. Applied to a reference prostate cancer dataset and a newly generated breast cancer dataset, Tumoroscope reveals spatial patterns of clone colocalization and mutual exclusion in sub-areas of the tumor tissue. We further infer clone-specific gene expression levels and the most highly expressed genes for each clone. In summary, Tumoroscope enables an integrated study of the spatial, genomic, and phenotypic organization of tumors.
2 October 2026 in Bioinformatics
Motivation: Tumors are heterogeneous mixtures of clonal subpopulations of cells that co-evolve in time and space. Apart from genetic differences, cancer clones may reside in different locations in the tumor tissue and show various transcriptional phenotypes, with specific gene expression profiles and marker genes. Computational tools that simultaneously infer genotypes and transcriptional phenotypes of clones in tumor tissues are lacking. Results: We introduce ClonalGE, a probabilistic graphical model identifying cancer clone genotypes, their gene expression profiles, and spatial mapping within tumor tissue. The model proceeds by probabilistic matching of single nucleotide variant sites in spatial transcriptomics to clone-specific variants inferred from DNA sequencing data, and by deconvoluting gene expression in spatial transcriptomics spots into contributions from individual clones. We propose a procedure that utilizes the Monte Carlo posterior samples for identification of differentially expressed genes between clones, using a Highest Density Interval plus Region of Practical Equivalence (HDI+ROPE) criterion that jointly requires credible and practically meaningful effect sizes. ClonalGE demonstrates superior performance on simulated data. Applied to a prostate cancer sample, it reveals clone-specific expression patterns and outperforms its predecessor model in accurately inferring gene expression profiles and explaining spatial transcriptomics signals. Our approach advances the functional and phenotypic characterization of clonal cell subpopulations in tumors. Availability: The implementation of ClonalGE and the data used in this study can be accessed in the following GitHub repository https://github.com/szczurek-lab/ClonalGE/. The benchmarking data alongside the intermediate results are available on Zenodo at DOI: 10.5281/zenodo.20446991.